SciELO - Scientific Electronic Library Online

 
vol.55 número3Desarrollo e implementación de guías para el aseguramiento de la calidad en el tamizaje de cáncer de mama: la experiencia europeaAnálisis retrospectivo de la Encuesta Nacional de Adicciones 2008: Identificación y corrección de sesgo índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Salud Pública de México

versão impressa ISSN 0036-3634

Resumo

WIRTZ, Veronika J; DRESER, Anahí  e  HEREDIA-PI, Ileana. Challenges and opportunities for the development of a national pharmaceutical policy in México. Salud pública Méx [online]. 2013, vol.55, n.3, pp.329-336. ISSN 0036-3634.

Unlike many other Latin American countries Mexico has no coherent and explicit national pharmaceutical policy (NPP). Other national challenges are: high out-of-pocket expenditure on medicines despite the implementation of universal health care coverage through Seguro Popular, high prices of medicines in the private sector in comparison to other countries when adjusted for income level, and the lack of clear strategies to improve safety and efficiency in the use of medicines, in particular interventions aimed at private physicians, pharmacies and consumers. The aim of this paper is to describe the challenges and opportunities to (1) consolidate the processes of formulating, implementing and evaluating NPP, and (2) define the policy content with regard to access and use of medicines.

Palavras-chave : medicines; drug utilization; policy making; pharmaceutical policy; Mexico.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )